Copyright
©The Author(s) 2016.
World J Respirol. Mar 28, 2016; 6(1): 14-23
Published online Mar 28, 2016. doi: 10.5320/wjr.v6.i1.14
Published online Mar 28, 2016. doi: 10.5320/wjr.v6.i1.14
Table 1 Summary of characteristics and main results of the studies published on Multidimensional-scoring systems
| Ref. | Type of study (number of patients) | Variables included in the model | Summary of results |
| Gay et al[76] | Prospective (38) | HRCT score | HRCT fibrotic score ≥ 2: 80% sensitive and 85% specific in predicting death (34 mo average follow-up). The CRP does not add predicting value |
| Pathology fibrotic score | |||
| King et al[77] | Retrospective (91) | Age | Only prediction results of single variables are reported by the authors. No direct data about performance of the CRP are reported |
| Smoking status | |||
| Clubbing | |||
| HRCT score | |||
| HRCT score for PH | |||
| TLC % pred | |||
| PaO2 at max exercise | |||
| Mogulkoc et al[78] | Retrospective (95) | HRCT score | HRCT and DLCO% combined model: AUC 0.91; sensitivity 84%, specificity 82% in predicting 2 yr survival |
| DLCO % pred | |||
| Wells et al[79] | Retrospective (212) | DLCO % pred | 5 yr survival CPI regression coefficient: 0.092 (0.043, 0.141). P < 0.0005 |
| FVC % pred | |||
| FEV1 % pred | |||
| du Bois et al[80] | Prospective (830) | Age | Combined scoring system AUC: 0.75. 1 yr survival |
| Respiratory hospitalization | |||
| FVC % pred | |||
| 24 wk in FVC % pred | |||
| Richards et al[29] | Prospective (241) | Gender | PCMI ≥ 330: AUC 0.74-0.84 in predicting survival. Average follow-up 1.8 yr |
| FVC %pred | |||
| DLCO %pred | |||
| MMP-7 | |||
| Mura et al[82] | Prospective (138) | MRCDS | ROSE > 2:HR 11.4, P < 0.0001; AUC 0.76; sensitivity 39%, specificity 100% in predicting survival. 3 yr follow-up |
| 6MWD % pred | |||
| CPI | |||
| Ley et al[83] | Retrospective (558) | Gender | GAP: c-index 69.3. Stages I, II and III 1-yr mortality of 6%, 16%, and 39%, respectively |
| Age | |||
| FVC % pred | |||
| DLCO % pred |
Table 2 Risk stratification Score[82]
| Low risk (all of the following conditions) | Intermediate risk (1 or 2 of the following conditions) | High risk (all the following conditions) |
| MRCDS ≤ 3 | MRCDS > 3 | MRCDS > 3 |
| 6MWD > 72% predicted | 6MWD 72% ≤ predicted | 6MWD 72% ≤ predicted |
| CPI ≤ 41 | CPI > 41 | CPI > 41 |
Table 3 Gender, age, physiology index[83]
| Stage | I | II | III |
| Points | 0-3 | 4-5 | 6-8 |
| Predictor | Points | ||
| Gender | |||
| G | Female | 0 | |
| Male | 1 | ||
| Age | |||
| A | ≤ 60 | 0 | |
| 61-65 | 1 | ||
| ≥ 65 | 3 | ||
| FVC% predicted | |||
| > 75 | 0 | ||
| 50-75 | 1 | ||
| P | < 50 | 2 | |
| DLCO% predicted | |||
| > 55 | 0 | ||
| 36-55 | 1 | ||
| ≤ 35 | 2 | ||
| Cannot perform | 3 | ||
| Total possible points | 8 |
- Citation: Puxeddu E, Rogliani P. Prognostic scoring systems for clinical course and survival in idiopathic pulmonary fibrosis. World J Respirol 2016; 6(1): 14-23
- URL: https://www.wjgnet.com/2218-6255/full/v6/i1/14.htm
- DOI: https://dx.doi.org/10.5320/wjr.v6.i1.14
